Biological isolate - United Paragon Associates

Drug Profile

Biological isolate - United Paragon Associates

Alternative Names: Fertilized egg extract - United Paragon Associates; Rellidep

Latest Information Update: 27 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator United Paragon Associates
  • Class Antidepressants; Stem cell therapies
  • Mechanism of Action Glutamate receptor modulators; Neurokinin 2 receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Major depressive disorder

Highest Development Phases

  • No development reported Major depressive disorder

Most Recent Events

  • 26 Feb 2016 No development reported - Phase-II/III for Major depressive disorder in Canada (PO)
  • 17 Dec 2013 Biological isolate - United Paragon Associates is available for licensing as of 17 Dec 2013.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top